Whether these adoptive cells were in the spleen, peripheral blood, or the tumor itself, our findings showed that the CD8+ T cells in the DC/tumor FC + LPS-RGD-Nb36-DOX group remained for almost 4 weeks as well as remained longer within tumor-bearing mice compared with control categories. The gene discussed is CD8A; the disease is neoplasm.